PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview PART 06: Infectious disease landscape in the US • Reimbursement in US • Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration • Five forces analysis PART 07: Market segmentation by technology • Molecular diagnostic test • POCT for infectious diseases • Immunodiagnostic tests PART 08: Market segmentation by application PART 09: Market segmentation by product • Equipment • Consumables PART 10: Market drivers • NAFTA • Demand for rapid and automated diagnostics • Shift toward patient-centered model • Focus on disease management PART 11: Impact of drivers PART 12: Market challenges • Medical device excise tax law • Increase in globalization • New microbial diseases PART 13: Impact of drivers and challenges PART 14: Market trends • Development of innovative diagnostics initiatives • Key role of US Army Medical Research Institute in Diagnostics and Development (USAMRIID) • Low-cost microfluidic devices for POCT • Focus on early diagnosis of infectious diseases PART 15: Vendor landscape • Competitive scenario • Abbott Diagnostics • Alere • Roche Diagnostics • Siemens Healthcare • Beckman Coulter Diagnostics • Other prominent vendors PART 16: Key vendor analysis • Abbott Diagnostics • Alere • Beckman Coulter • Roche Diagnostics • Siemens Healthcare PART 17: Appendix • List of abbreviations PART 18: Explore Technavio LOE Exhibit 01: Product offerings Exhibit 02: Infectious disease testing market in US 2014-2019 ($ billions) Exhibit 03: Average Medicare payments for infectious diseases Exhibit 04: Five forces analysis Exhibit 05: Segmentation of infectious disease testing market in US based on technology Exhibit 06: Molecular diagnostic testing market in US 2014-2019 ($ billions) Exhibit 07: POCT diagnostic testing market for infectious diseases in US 2014-2019 ($ billions) Exhibit 08: Immunodiagnostic tests for infectious disease market in US 2014-2019 ($ billions) Exhibit 09: Segmentation of infectious disease market in US by technology 2014 Exhibit 10: POCT for infectious diseases market in US by application Exhibit 11: Segmentation of POCT for infectious disease market in US 2014 Exhibit 12: Infectious disease testing market in US by product Exhibit 13: Segmentation of infectious disease testing market in US by product 2014 Exhibit 14: Impact of drivers Exhibit 15: Impact of drivers and challenges Exhibit 16: Key Takeaways: Abbott Diagnostics Exhibit 17: Key takeaways: Alere Exhibit 18: Key takeaways: Roche Diagnostics Exhibit 19: Key takeaways: Siemens Healthcare Exhibit 20: Key takeaways: Beckman Coulter Diagnostics Exhibit 21: Abbott Diagnostics: Key business offerings Exhibit 22: Alere: Business segmentation by revenue 2014 Exhibit 23: Alere: Business segmentation by revenue 2013 and 2014 ($ millions) Exhibit 24: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions) Exhibit 25: Beckman Coulter: Business segmentation Exhibit 26: Roche Diagnostics: Business segmentation by revenue 2014 Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 28: Roche Diagnostics: Segmentation of revenue by regions 2014 Exhibit 29: Siemens Healthcare: Business segmentation Exhibit 30: Siemens Healthcare: Segmentation of revenue by geography 2014

Abbott Diagnostics, Alere, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies, Maxim Biomedical, Mindray, OraSure Technologies, Ortho Clinical Diagnostics, Quidel Corporation, Thermo Fisher Scientific, Trinity Biotech.